This site might not work as expected.
You're using an old browser that isn't supported by this site. Please upgrade or download one of these free and excellent browsers: https://browser-update.org/update.html

Wolters Kluwer Announces Transplantation Direct Journal

Fully Open Access Journal to Publish Research in the Field of Transplantation

​Wolters Kluwer is pleased to announce the January 2015 release of Transplantation Direct, an open access journal created as a companion to Transplantation ®, the official journal of The Transplantation Society. This journal is accepting manuscripts now at  editorialmanager.com/txd.

"The launch of Transplantation Direct is an important development, one that expands our ability to provide scientific innovation and educational material to a global audience," said Jeremy Chapman, MD, Editor-in-Chief of both Transplantation and Transplantation Direct. "As an open access publication, Transplantation Direct offers important studies immediately to researchers and practitioners worldwide in perpetuity."

Transplantation Direct, the latest fully open access journal from Wolters Kluwer's Lippincott Williams & Wilkins publishing portfolio, is an international portal for the rapid electronic publication of high-quality basic research and clinical studies related to the field of transplantation. Submissions will be peer-reviewed by leaders within The Transplantation Society to create an online repository of significant, high quality research. As a complementary journal to Transplantation, Transplantation Direct will provide an open access venue for research studies sponsored by private and public funding agencies that require open access publication.

Article types published in Transplantation Direct include:

  • Standard original basic or clinical science articles
  • Brief preliminary reports on experimental or clinical findings
  • Clinical trial protocols of special high interest
  • New methodologies and technical papers
  • Articles proposing novel, as yet untested, hypotheses
  • Articles stemming from current research affiliated with TTS-associated societies
  • Publication of registry reports
  • Commentaries

"Transplantation has long been a leading journal in its field, now this complementary open access title will provide a valuable portal of high quality research in this specialty," said Jayne Marks, Vice President, Publishing for Wolters Kluwer, Medical Research.

Transplantation Direct will provide rapid review and publication of accepted papers; all articles and content are published under the Creative Commons License Attribution Non-Commercial No Derivative 3.0 License (CCBY-NC-ND). For more details about the journal, please see  editorialmanager.com/txd.

About Transplantation Direct
Transplantation Direct is an open access, peer-reviewed, international journal offering rapid electronic publication of high quality basic research and clinical studies related to the field of transplantation. The journal seeks to provide both scientific innovation and educational material, to disseminate vital registry database information and to highlight key scientific advances presented at meetings held by the global transplantation associations. The inherent flexible capacity of multimedia electronic publishing will be combined with high standards of peer review set by exceptional leaders within The Transplantation Society to allow for an inclusive, comprehensive, and yet rigorous approach to presenting significant developments in transplantation.

About The Transplantation Society
The Transplantation Society (TTS) is a Non-Governmental Organization (NGO) that serves as an international forum for the worldwide advancement of organ transplantation. With more than 6,400 members composed of professionals with an active interest in basic science, clinical research, scientific communication, education, guidance on ethical practices and improving clinical practice in the field of transplantation,  TTS is truly an international body with members in all parts of the globe.

About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health's market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include  Health Language ®Lexicomp ®Lippincott Williams & WilkinsMedicom®Medi-Span ®MedknowOvid ®Pharmacy OneSource®ProVation ® Medical and  UpToDate ®.

Wolters Kluwer Health is part of  Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Follow our official Twitter handle:  @WKHealth.